Innate host cell responses to viral infection are important factors that play major roles in viral pathogenesis, adaptive immunity, and tropism for specific tissues or cells (2). These antiviral responses include the stimulation of type I interferon (IFN) pathways and the secretion of proinflammatory cytokines, such as interleukin-6 (IL-6) and 41). Paramyxoviruses, such as simian virus 5 (SV5), can prevent activation of host antiviral responses by directly inhibiting the pathways that lead to activation (4) or by attenuating the expression of viral products that are the activators of a host cell response (9). Here we provide evidence for the role of the viral genomic promoter in enabling SV5 to avoid activation of innate responses.Members of the paramyxovirus family of negative-strand RNA viruses employ a diverse range of mechanisms to circumvent host cell antiviral responses (reviewed in references 7 and 15). Many of these mechanisms for counteracting cytokine responses have been attributed to products of the paramyxovirus P/V (or P/V/C) gene, which, depending on the particular virus, encodes the phosphoprotein P subunit of the RNAdependent RNA polymerase, the accessory V protein, and in some cases the family of C proteins (8,26,14,33). For SV5, accurate transcription of the P/V gene results in an mRNA coding for the V protein. The P mRNA is identical to the V mRNA except for the addition of two nontemplated G residues that are inserted by the viral polymerase at a precise location in the P/V transcript (44). The P and V proteins have unique C-terminal regions, with the V protein encoding a highly conserved cysteine-rich domain that is required for many V-associated functions (8,17,38).A major function of the SV5 V protein is the inhibition of IFN signaling, which occurs through V-mediated targeting of signal transducer and activator of transcription 1 (STAT1) for ubiquitylation and degradation (1,8,45). The SV5 V protein also blocks activation of the IFN- promoter during virus infection (17) or following transfection of double-stranded RNA (dsRNA) (4, 38). The paramyxovirus V protein inhibits IFN- induction by targeting the IFN-inducible RNA helicase encoded by the melanoma differentiation-associated gene 5 (mda-5) (4, 5). Inhibition of mda-5 activation requires only the V protein cysteine-rich C-terminal domain (4, 38), which prevents mda-5 from binding dsRNA and self-association (5). In contrast, the alternative RNA helicase retinoic acid-inducible gene I (RIG-I) does not appear to be inhibited by V protein (4, 5). V protein also appears to act as a decoy substrate for kinases that activate IFN regulatory factor 3 (IRF-3) (29) and . Similarly, the SV5 V protein is reported to block IL-6 induction (27), although virus-infected cells still respond to tumor necrosis factor alpha-mediated induction of .In addition to the V protein, some paramyxoviruses, such as Sendai virus (SeV) and measles virus, encode a group of C proteins that are expressed from the P/V/C gene (26). The SeV